Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1993 1
1995 1
1997 3
1998 7
1999 5
2000 12
2001 7
2002 16
2003 21
2004 10
2005 12
2006 27
2007 38
2008 40
2009 47
2010 45
2011 46
2012 58
2013 45
2014 60
2015 80
2016 59
2017 66
2018 99
2019 79
2020 70
Text availability
Article attribute
Article type
Publication date

Search Results

757 results
Results by year
Filters applied: . Clear all
Page 1
Re: Philipp Mandel, Felix Preisser, Markus Graefen, et al. High Chance of Late Recovery of Urinary and Erectile Function Beyond 12 Months After Radical Prostatectomy. Eur Urol 2017;71:848-50: Late Recovery of Erectile Function After Radical Prostatectomy: Should We Modify the Way of Assessment?
Capogrosso P, Montorsi F, Salonia A. Capogrosso P, et al. Eur Urol. 2017 Dec;72(6):e177-e178. doi: 10.1016/j.eururo.2017.07.001. Epub 2017 Jul 14. Eur Urol. 2017. PMID: 28716369 No abstract available.
Re: Philipp Mandel, Felix Preisser, Markus Graefen, et al. High Chance of Late Recovery of Urinary and Erectile Function Beyond 12 Months After Radical Prostatectomy. Eur Urol 2017;71:848-50.
Kim JH, Lee B, Chung BI. Kim JH, et al. Eur Urol. 2017 Dec;72(6):e175. doi: 10.1016/j.eururo.2017.06.033. Epub 2017 Jul 11. Eur Urol. 2017. PMID: 28709728 No abstract available.
Reply to Paolo Capogrosso, Francesco Montorsi, and Andrea Salonia's Letter to the Editor re: Philipp Mandel, Felix Preisser, Markus Graefen, et al. High Chance of Late Recovery of Urinary and Erectile Function Beyond 12 Months After Radical Prostatectomy. Eur Urol 2017;71:848-50. Late Recovery of Erectile Function After Radical Prostatectomy: Should We Modify the Way of Assessment?
Mandel P, Graefen M, Huland H, Tilki D. Mandel P, et al. Eur Urol. 2017 Dec;72(6):e179. doi: 10.1016/j.eururo.2017.07.002. Epub 2017 Jul 13. Eur Urol. 2017. PMID: 28712858 No abstract available.
Reply to Jae Heon Kim, Bora Lee, and Benjamin I. Chung's Letter to the Editor re: Philipp Mandel, Felix Preisser, Markus Graefen, et al. High Chance of Late Recovery of Urinary and Erectile Function Beyond 12 Months After Radical Prostatectomy. Eur Urol 2017;71:848-50.
Mandel P, Tilki D. Mandel P, et al. Eur Urol. 2017 Dec;72(6):e176. doi: 10.1016/j.eururo.2017.06.034. Epub 2017 Jul 11. Eur Urol. 2017. PMID: 28709729 No abstract available.
Eine randomisierte, offene, Multizenterstudie zum Einsatz von Cabazitaxel versus einem Androgenrezeptor (AR)-gerichteten Präparat (Abirateron oder Enzalutamid) bei Patienten mit mCRPC nach Vorbehandlung mit Docetaxel und frühem Nicht-Ansprechen nach AR-gerichtetem Präparat (CARD) – Studie AP 97/17 der AUO.
Rexer H, Graefen M, Wülfing C. Rexer H, et al. Aktuelle Urol. 2018 Jun;49(3):222-224. doi: 10.1055/a-0596-4618. Epub 2018 May 22. Aktuelle Urol. 2018. PMID: 29788522 German. No abstract available.
AUTHOR REPLY.
Knipper S, Graefen M, Karakiewicz PI. Knipper S, et al. Urology. 2019 Nov;133:142-143. doi: 10.1016/j.urology.2019.05.055. Urology. 2019. PMID: 31706414 No abstract available.
Zweitlinientherapie beim metastasierten kastrationsrefraktären Prostatakarzinom (mCRPC).
Rexer H, Graefen M, Merseburger A. Rexer H, et al. Aktuelle Urol. 2019 Sep;50(5):478-479. doi: 10.1055/a-0901-9007. Epub 2019 Aug 29. Aktuelle Urol. 2019. PMID: 31466095 German. No abstract available.
Re: Shear Wave Elastography for Localization of Prostate Cancer Lesions and Assessment of Elasticity Thresholds: Implications for Targeted Biopsies and Active Surveillance Protocols: K. Boehm, G. Salomon, B. Beyer, J. Schiffmann, K. Simonis, M. Graefen and L. Budaeus J Urol 2015;193:794-800.
Ozkan F, Ozel D, Bayraktarli RY, Coskun ZU. Ozkan F, et al. J Urol. 2015 Oct;194(4):1167. doi: 10.1016/j.juro.2015.04.084. Epub 2015 Jun 29. J Urol. 2015. PMID: 26133562 No abstract available.
Re: Use of Phosphodiesterase Type 5 Inhibitors May Adversely Impact Biochemical Recurrence after Radical Prostatectomy: U. Michl, F. Molfenter, M. Graefen, P. Tennstedt, S. Ahyai, B. Beyer, L. Budaus, A. Haese, H. Heinzer, S. J. Oh, G. Salomon, T. Schlomm, T. Steuber, I. Thederan, H. Huland and D. Tilki J Urol 2015;193:479-483.
Bora GS, Gupta VG, Mavuduru RS. Bora GS, et al. J Urol. 2016 Mar;195(3):804; discussion 804-5. doi: 10.1016/j.juro.2015.08.103. Epub 2015 Nov 25. J Urol. 2016. PMID: 26627733 No abstract available.
Phase-III-Studie beim lokalen oder lokal fortgeschrittenen Prostatakarzinom: Randomisierte, doppelblinde, Placebo-kontrollierte Phase 3 Studie zu Apalutamide in Patienten mit lokalem Hoch-Risiko-Prostatakarzinom oder lokal fortgeschrittenem Prostatakarzinom, die eine primäre Radiotherapie erhalten (ATLAS) – Studie AP 90/15 der AUO.
Rexer H, Graefen M Prof Dr, Grimm MO Prof Dr. Rexer H, et al. Aktuelle Urol. 2017 Dec;48(6):520-521. doi: 10.1055/s-0043-119917. Epub 2017 Dec 7. Aktuelle Urol. 2017. PMID: 29216658 Clinical Trial. German. No abstract available.
757 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback